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Cigarette Smoking Strongly Modifies the Association of LOC387715
and Age-Related Macular Degeneration
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We used iterative association mapping to identify a susceptibility gene for age-related macular degeneration (AMD)
on chromosome 10q26, which is one of the most consistently implicated linkage regions for this disorder. We
employed linkage analysis methods, followed by family-based and case-control association analyses, using two
independent data sets. To identify statistically the most likely AMD-susceptibility allele, we used the Genotype-
IBD Sharing Test (GIST) and conditional haplotype analysis. To incorporate the two most important known AMD
risk factors—smoking and the Y402H variant of the complement factor H gene (CFH)—we used logistic regression
modeling to test for gene-gene and gene-environment interactions in the case-control data set and used the ordered-
subset analysis to account for genetic linkage heterogeneity in the family-based data set. Our results strongly implicate
a coding change (Ala69Ser) in the LOC387715 gene as the second major identified AMD-susceptibility allele,
confirming earlier suggestions. This variant’s effect on AMD is statistically independent of CFH and is of similar
magnitude to the effect of Y402H. The overall effect is driven primarily by a strong association in smokers, since
we observed significant evidence for a statistical interaction between the LOC387715 variant and a history of
cigarette smoking. This gene-environment interaction is supported by statistically independent family-based and
case-control analysis methods. We estimate that CFH, LOC387715, and cigarette smoking together explain 61%
of the population-attributable risk (PAR) of AMD. The adjusted PAR percentage estimates are 20% for smoking,
36% for LOC387715, and 43% for CFH. We demonstrate, for the first time, that a genetic susceptibility coupled
with a modifiable lifestyle factor such as cigarette smoking confers a significantly higher risk of AMD than either
factor alone.
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Age-related macular degeneration (AMD) is a common
complex disorder that affects the central region of the
retina (macula) and is the leading cause of legal blindness
in white Americans aged 165 years. The prevalence of
AMD and its significant morbidity will rise sharply as
the population ages. AMD is a clinically heterogeneous
disorder with a poorly understood etiology. Population-
based longitudinal studies1,2,3 have established that the
presence of extracellular protein and/or lipid deposits
(drusen) between the basal lamina of the retinal pigment
epithelium (RPE) and the inner layer of the Bruch’s
membrane is associated with an increased risk of pro-
gressing to an advanced form of AMD, either geographic
atrophy (dry AMD) or choroidal neovascularization
(wet AMD). The presence of large and indistinct (soft)
drusen, coupled with RPE abnormalities, is considered
to be an early form of the disorder and is often referred
to as “age-related maculopathy.”
Epidemiologically, AMD is a complex disorder, with
contributions of environmental factors and genetic sus-
ceptibility.4 Many environmental and lifestyle factors
have been postulated, but the strongest nongenetic risk
factor for AMD is clearly cigarette smoking.5,6 Much
progress has been made recently in identifying and char-
acterizing the genetic basis of AMD. In a remarkable
example of the convergence of methods for disease-gene
discovery, multiple independent research efforts identi-
fied the Y402H variant in CFH (the complement factor
H [MIM 134370]) on chromosome 1q32 as the first
major AMD-susceptibility allele.7–12 Whereas one of the
studies was able to pinpoint CFH on the basis of a
whole-genome association study,9 most focused on the
1q32 region because it had been implicated consistently
by several whole-genome linkage scans. A second ge-
nomic region with similarly consistent linkage evidence
is chromosome 10q26, which was identified as the single
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Table 1
Demographic and Clinical Characteristics of the Study Population
CHARACTERISTIC
FAMILY
DATA SET
INDEPENDENT
CASE-CONTROL DATA SET
Cases Controls
No. of multiplex families 140 … …
No. of affected sibling pairsa 169 … …
No. of other affected relative pairsa 37 … …
No. of singleton families 60 … …
No. of discordant sibling pairsb 158 … …
No. of individuals 526 610 259
No. (%) with macular findings:
Grade 1c 85 (16.2) … 193 (74.5)
Grade 2d 50 (9.5) … 66 (25.5)
Grade 3e 109 (20.7) 140 (23.0) …
Grade 4f 61 (11.6) 77 (12.6) …
Grade 5g 221 (42.0) 393 (64.4) …
No. (%) female 348 (66.2) 396 (64.9) 148 (57.1)
Mean (SD) age at examination (years) 72.6  9.9 76.8  7.7 66.7  8.1
a In multiplex families.
b In multiplex and singleton families.
c No drusen or nonextensive small (!63 mm) drusen without RPE abnormalities.
d Extensive small drusen or nonextensive intermediate (63 mm and !125 mm) drusen
and/or RPE hyper- or hypopigmentation.
e Extensive intermediate drusen or any large (125 mm), soft drusen, including dru-
senoid RPE detachment.
f Geographic atrophy (area of RPE atrophy with sharp margins, usually visible cho-
roidal vessels, at least 175 mm in diameter).
g Exudative AMD, including nondrusenoid RPE detachment, choroidal neovascu-
larization, subretinal hemorrhage or fibrosis, or photocoagulation scar consistent with
treatment of AMD.
most-promising region by a recent meta-analysis of pub-
lished linkage screens.13
Two recent studies have suggested specific AMD-sus-
ceptibility genes that are located on chromosome 10q26.
One study used a combination of family-based and case-
control analyses to implicate PLEKHA1 (pleckstrin ho-
mology domain–containing, family A, member 1 [MIM
607772]) and the predicted LOC387715 gene.14 How-
ever, the association signals for SNPs in these two genes
were statistically indistinguishable. The other study used
two independent case-control data sets and concluded
that the T allele of SNP rs10490924 in LOC387715, a
coding change (Ala69Ser) in exon 1 of this poorly char-
acterized gene, was the most likely AMD-susceptibility
allele.15 Both studies reported that the chromosome
10q26 variant confers an AMD risk similar in magnitude
to that conferred by the Y402H variant in CFH. Here,
we describe highly significant association of SNPs in
LOC387715 with AMD. In our data, only SNPs in this
gene, including rs10490924, explained the strong link-
age and association signal in this region. Given a pre-
vious report of an effect of cigarette smoking on the
linkage findings in the 10q26 region,16 we tested whether
smoking modifies this association. Our data suggest that
variant genotypes at rs10490924 confer a substantially
larger AMD risk to cigarette smokers than to non-
smokers. This observation is supported by traditional
case-control modeling; by ordered-subset linkage anal-
ysis (OSA), incorporating pack-years of cigarette smok-
ing as a covariate; and by family-based association anal-
ysis, using a more homogeneous set of families as defined
by OSA.
Subjects and Methods
Study Population
As part of an ongoing, large-scale study of genetic and en-
vironmental risk factors for AMD, we ascertained patients
with AMD, their affected and unaffected family members, and
a group of unrelated controls of similar age and ethnic back-
ground at two sites in the southeastern United States: Duke
University Eye Center (DUEC) and Vanderbilt University Med-
ical Center (VUMC). By use of stereoscopic color fundus pho-
tographs, all enrolled individuals were assigned (by E.A.P. and
A.A.) one of five different grades of macular findings, as de-
scribed elsewhere17,18 and summarized in table 1. Our AMD
classification is a modification of the Age-Related Eye Disease
Study grading system, with the use of Wisconsin grading-
system example slides19 and the International Classification
System20 as guides. The more severely affected eye was used
to classify each individual. Unrelated controls were enrolled
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via (i) study advertisement in DUEC- and VUMC-specific
newsletters; (ii) recruitment presentations by study coordina-
tors at local retirement communities, the residents of which
were likely to obtain health care at DUEC or VUMC; and (iii)
AMD-related seminars for the general public sponsored by
DUEC or VUMC ophthalmology clinics. Spouses of patients
with AMD were also asked to participate as controls. All cases
and controls included in this study were white and at least 55
years old. The study protocol was approved by the institutional
review boards of the Duke University Medical Center and
VUMC, the research adhered to the tenets of the Declaration
of Helsinki, and informed consent was obtained from all study
participants. Blood samples were collected, and genomic DNA
was extracted from whole blood by using the PureGene system
(Gentra Systems) on an Autopure LS.
Information about the smoking history of study participants
was obtained from a self-administered questionnaire that was
formatted to maximize readability for individuals with low
vision. However, if participants indicated that they could not
complete the form, a project coordinator offered to assist the
participants in filling out the questionnaire. Regular cigarette
smoking was assessed by two questions: (1) “Have you smoked
at least 100 cigarettes in your lifetime?” and (2) “Did you ever
smoke cigarettes at least once per week?”. Individuals an-
swering “yes” to both questions were asked the average num-
ber of cigarettes they smoked per day, the year that they started
smoking, whether they had quit smoking, and, if so, what year.
This information was used to calculate pack-years of smoking
as (cigarettes per day# years smoked)/20 cigarettes per pack.
The most general measurement of smoking history was con-
structed as a binary “ever or never” variable based on a par-
ticipant’s response to question (1) above.
The study population for the analysis presented here in-
cluded 810 unrelated patients with early (grade 3) or advanced
(grades 4 and 5) AMD. Of these, 200 had at least one sampled
(affected or unaffected) relative and thus contributed to the
family-based association analysis. The remaining 610 patients
with AMD who did not have sampled relatives and 259 un-
related controls without AMD (grades 1 and 2) made up an
independent case-control data set. Demographic and clinical
information for these individuals and their relatives (1,395
individuals total) is shown in table 1.
Genotyping and Linkage and Association Analysis
Previous work by our group21 and by others16,22–24 suggested
the presence of an AMD-susceptibility locus on chromosome
10q26, with the linkage peak centered at ∼122 Mb. To narrow
the region most likely to harbor an AMD-susceptibility allele,
we genotyped SNPs in the 112–132-Mb interval, which ex-
tended 10 Mb on either side of the reported linkage peak. We
started with a density of ∼1 SNP per 1 Mb and filled in the
117–127-Mb region immediately surrounding the 122-Mb
peak with a higher density of 1 SNP per 140 kb on average.
All SNPs were selected using SNPSelector software25 to have
approximately equal spacing and minor-allele frequency
(MAF) 5%. Genotyping was performed with the TaqMan
allelic discrimination assay, by use of either Assays-On-
Demand or Assays-By-Design products (Applied Biosystems).
For quality-control purposes, two CEPH standards were in-
cluded in each 96-well plate, and samples from six individuals
were duplicated across all plates, with the laboratory techni-
cians blinded to their identities. Analysis required matching
quality-controlled genotypes within and across plates and at
least 95% genotyping efficiency. The Y402H variant in CFH
was genotyped by sequencing, as described elsewhere.7
After the first round of genotyping and statistical analysis,
we applied iterative association mapping26 to select another
set of SNPs in the peak region, defined approximately as the
1-LOD support interval surrounding the peak multipoint LOD
score (123.8–126.6 Mb). Our final SNP density was an average
of 1 SNP per 33 kb, for a total of 84 SNPs in the 2.8-Mb
support interval. Outside this interval, 101 SNPs were geno-
typed in the 112–132-Mb region, for a total of 185 SNPs. In
addition to using SNPSelector,25 SNPs were identified through
resequencing of LOC387715 and CUZD1 (CUB and zona
pellucida–like domains 1 [HGNC accession number 17937])
in 48–72 unrelated, affected and unaffected individuals. We
chose to sequence only LOC387715 and CUZD1, because
they were the only genes that harbored SNPs with statistically
significant association signals when the false-discovery rate
(FDR) was used to correct for multiple testing and controlled
at a level of 5%. Individuals were selected for resequenc-
ing on the basis of homozygosity at SNP rs10490924 in
LOC387715 and SNP rs1891110 in CUZD1. The reason for
this selection was that individuals homozygous for the risk-
associated variant would be most likely to carry the risk allele
at a different intragenic sequence variant. Thus, if the observed
association were due to linkage disequilibrium (LD) with an
untyped causal variant, this should maximize the probability
of identifying this variant.
The genotype data were analyzed with MERLIN27 (for
MERLIN software, see Center for Statistical Genetics Web site)
to calculate nonparametric two-point and multipoint LOD
scores under the exponential model, denoted as LOD*.28 Allele
frequencies were estimated from all genotyped individuals.
Parametric affecteds-only heterogeneity LOD scores (HLODs)
under a dominant (disease-allele frequency 0.01) or recessive
(disease-allele frequency 0.2) model were also computed with
MERLIN. To avoid an inflation of linkage evidence due to
intermarker LD,29 we used recently described methods for es-
timating haplotype frequencies of SNP clusters in high pairwise
LD, using a threshold of to define these clusters.302r p 0.16
The LD pattern in the region of interest was analyzed with the
Haploview program,31 with the generated genotypes from un-
related patients with AMD as the input. Association analysis
was applied to all 185 SNPs, by use of the family-based as-
sociation in the presence of linkage (APL) test32 (for APL soft-
ware, see Center for Human Genetics Web site) and standard
logistic regression analysis for case-control comparisons with
adjustment for age and sex (SAS version 8.02 [SAS Institute]).
An additive coding scheme was used, with the SNP model
covariate taking on the values 1, 0, and 1 for genotypes 1/
1, 1/2, and 2/2, respectively, where 2 is the minor allele in
controls. As described above, we divided our total sample into
cases contributing to the APL analysis (affected individuals
with at least one sampled relative; families) and annp 200
independent sample of cases without sampled relatives (np
) who were compared with 259 unrelated controls.610
As mentioned above, we used the FDR to correct for multiple
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Table 2
SNPs Identified in LOC387715 Sequencing of Individuals Homozygous for
rs1891110 or rs10490924 Variant, by AMD Grade
VARIANTa
MINOR ALLELE (MAF)
IN HOMOZYGOTES FOR
rs1891110 Variant rs10490924 Variant
Grade 1 Grade 5 Grade 1 Grade 5
rs10490923 A (.11) A (.14) ND ND
rs2736911 T (.188) T (.159) ND ND
rs10490924 T (.188) T (.523) ND ND
rs17623531 T (.11) T (.077) ND ND
C124204957T (ss51855974) T (1) T (.04) ND ND
G124204966T (ss51855975) T (.060) T (.538) T (1) T (1)
A124205188G (ss51855976) G (.189) G (.523) G (.974) G (.983)
T124205201C (ss51855977) C (.189) C (.523) C (.974) C (.983)
rs3750848 G (.189) G (.523) G (.974) G (.983)
rs3750846 C (.189) C (.523) C (1) C (1)
rs2736912 T (.167) T (.182) ND ND
rs3750847 T (.189) T (.523) T (1) T (1)
rs10664316 AT (.66) AT (.94) AT (1) AT (1)
T124206387C (ss51855978) C (.15) C (.16) ND ND
rs7088128 G (.15) G (.16) ND ND
NOTE.—ND p not determined.
a Physical location according to NCBI build 35.
testing.33 Only SNPs that were significant with an FDR of 5%
were analyzed with the Genotype-IBD Sharing Test (GIST)
method34 (for GIST software, see Center for Human Genetics
Research Web site) to examine which of the most strongly
associated SNPs best explained the linkage evidence in the
region. We also used the COCAPHASE module of the UN-
PHASED software package35 (see UNPHASED page at the
Medical Research Council Biostatisics Unit Web site) to per-
form conditional haplotype analysis. This analysis tested
whether conditioning on the risk allele at a particular SNP
accounted for the association signal in the region. If the as-
sociation signal in the region was driven by a single SNP, con-
ditioning on its effect was expected to remove all evidence of
association for the remaining SNPs.
Interaction Analysis
We conducted additional analyses to incorporate effects of
the two most important known AMD risk factors—smoking
and the CFH gene. First, we fit a series of logistic regression
models to the combined case-control data set (including pro-
bands from the family data set) to identify the model that best
described (1) the joint effects of CFH and LOC387715 and
(2) the joint effects of smoking and LOC387715. We followed
a recently proposed modeling strategy36 in which the best-
fitting model was derived on the basis of Akaike’s information
criterion (AIC). The AIC compares different models with a
log-likelihood ratio test that is penalized for the number of
model parameters to identify the most parsimonious model
that adequately fits the data. For each genotype, two model
terms were tested: one coding for additive effects at the first,
second, or both loci (ADD1, ADD2, and ADDBOTH), using
the coding described above, and the other coding for domi-
nance effects (DOM1, DOM2, and DOMBOTH). For ex-
ample, the ADD1 model contained only model term x1, coded
as 1 for genotype GG at rs10490924, as 0 for genotype GT,
and as 1 for genotype TT. The ADD2 model included only
model term x2, coded as 1 for genotype TT at Y402H, as 0
for genotype TC, and as 1 for genotype CC. Both models were
nested within the larger ADDBOTH model, which included
both x1 and x2 model terms. This model was again nested
within the larger DOMBOTH model, which included x1, x2,
and two additional terms: z1, coded as 0.5 for genotype GT
at rs10490924 and as 0.5 for genotypes GG and TT, and
z2, coded analogously for genotypes at Y402H. To test for
deviation from joint additive and joint dominance effects (on
the logarithmic scale), three additional models (ADDINT,
ADDDOM, and DOMINT) were fit. The ADDINT model in-
cluded the product term ; the ADDOM model includedx # x1 2
the product terms , , and ; and the DOM-x # x x # z x # z1 2 1 2 2 1
INT model included all the above product terms plus the term
. The model hierarchy was similar for testing the jointz # z1 2
effects of LOC387715 and smoking, except that smoking
was coded as 0 for never-smokers and 1 for ever-smokers, and
thus only two higher-order models (ADD_SMOKE_INT and
DOM_SMOKE_INT) were fit. Since all models are nested
within the largest model considered, their respective log-like-
lihood ratio statistics can be formally compared using the AIC
measure. Models for which the AIC differed by !2 units were
considered statistically indistinguishable,36 and the model with
the fewest parameters was chosen as the best fitting and most
parsimonious model. For example, when the ADDINT model
did not provide a substantially better fit than the ADDBOTH
model, this was interpreted as lack of evidence for statistical
interaction between the two factors. Thus, they each had in-
dependent main effects that were multiplicative (additive on
the logarithmic scale) such that the best estimate of the odds
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Table 3
SNPs Identified in CUZD1 Sequencing of Individuals Homozygous
for rs1891110 Variant, by AMD Grade
VARIANTa
MINOR ALLELE (MAF)
IN HOMOZYGOTES FOR
rs1891110 VARIANT
Grade 1 Grade 3 Grade 5
rs7908196 A (.184) ND A (.095)
rs11248321 A (.065) A (.023) A (.044)
A124585820G (ss51855956) G (.022) G (0) G (0)
C124586887T (ss51855957) T (0) T (0) T (.021)
A124586911G (ss51855958) G (.022) T (0) G (0)
C124587151T (ss51855959) T (0) T (0) T (.021)
A124590492G (ss51855960) G (0) G (0) G (.024)
C124595656T (ss51855961) T (.136) T (0) T (.136)
C124599157T (ss51855962) T (0) T (0) T (.022)
C124599185T (ss51855963) T (0) T (0) T (.022)
A124601941T (ss51855964) T (0) T (0) T (.022)
G124608497A (ss51855965) A (0) A (0) A (.021)
A124612240G (ss51855966) G (0) G (0) G (.021)
A124612340G (ss51855967) G (.043) G (.063) G (.042)
G124612380A (ss51855968) A (0) A (0) A (.021)
T124612649C (ss51855969) C (0) C (0) C (.021)
rs4638251 A (.184) A (.341) A (.357)
T124628837C (ss51855970) C (0) C (.045) C (.024)
C124629013T (ss51855971) T (0) T (0) T (.024)
A124629083G (ss51855972) G (0) G (0) G (.024)
rs2950355 T (.09) T (.022) T (.087)
rs2950354 T (.048) T (0) T (0)
rs9423288 T (.048) T (0) T (0)
rs10902838 A (.095) A (0) A (0)
rs11248323 T (.048) T (0) T (0)
T124647361A (ss51855973) A (0) A (0) A (.022)
rs11248329 C (.043) C (.022) C (.043)
rs4403744 G (.087) G (.022) G (.114)
rs1891113 T (.0) T (.023) T (0)
NOTE.—ND p not determined.
a Physical location according to NCBI build 35.
ratio (OR) for being exposed to both factors was the product
of the two main-effect ORs.
Our second approach for incorporating AMD-associated co-
variates was motivated by earlier reports that the 10q26 link-
age evidence resulted primarily from families with heavy smok-
ers.16 As in the previous study, we used an OSA37 (for OSA
software, see Center for Human Genetics Web site) with the
family-average of smoking pack-years as a covariate. To avoid
an undue influence of zero pack-years values on family aver-
ages, pack-years were coded as missing for nonsmokers. With
the high-to-low ordering of family-averaged pack-years, OSA
tested whether a subset of families with heavy smokers pro-
vided significantly greater linkage evidence than did the ref-
erence data set, which, in this case, was restricted to families
for whom nonmissing covariate values could be computed.
Thus, the baseline LOD score was computed for families in
which there was at least one affected smoker with pack-years
information.
Results
Linkage and Association Analysis
Resequencing of LOC387715 and CUZD1 identified
21 known and 23 novel SNPs (tables 2 and 3). Sequenc-
ing primers and conditions are available (from M.A.H.)
on request. Of these 44 SNPs, 19 were genotyped in our
entire data set. Genotypes for all SNPs analyzed here
were in Hardy-Weinberg equilibrium in unrelated con-
trols ( ). We observed high LD ( ) across′P 1 .01 D 1 0.9
a 60-kb region that included a frequent coding SNP
in exon 12 of PLEKHA1 (rs1045216), three coding
SNPs in LOC387715 (rs10490923, rs2736911, and
rs10490924), and several additional noncoding SNPs
in PLEKHA1 and LOC387715, replicating earlier ob-
servations.15 Notably, the adjacent downstream gene
PRSS11, also known as “HTRA1” (HtrA serine pepti-
dase 1 [MIM 602194]), was not included in this 60-kb
region (fig. 1).
In the family-based linkage analysis, a peak multipoint
LOD score was obtained at 124.7 Mb (HLOD 3.0 under
affecteds-only dominant model; nonparametric LOD*
2.6) (fig. 2). SNP rs10664316 in LOC387715 (124.2
Mb) gave a maximum nonparametric two-point LOD
score of 3.2. In the case-control analysis, four highly
correlated SNPs in LOC387715, including the frequent
and previously implicated coding change rs10490924 in
exon 1,15 were very strongly associated with AMD, with
logistic regression P values on the order of 108 (ta-
ble 4). The MAF of these highly correlated SNPs was
∼41.7% in cases, very similar to that reported by Rivera
et al.,15 and ∼25.8% in controls, somewhat higher than
the 19.6% reported by Rivera et al. Within the 60-kb
LD block and in the entire 20-Mb interval we screened,
association signals of this order of magnitude were ob-
served only for this set of highly correlated SNPs. In
particular, the coding SNP in exon 12 of PLEKHA1
(rs1045216) showed substantially weaker evidence for
association, both in terms of magnitude and statistical
significance (MAFcases 28.2%; MAFcontrols 36.8%; OR
0.6; ). Unlike in the previous reports, we de-Pp .02
tected a second region of association 400 kb distal to
LOC387715 that included several SNPs in CUZD1 and
an even more distal SNP in FAM24A (family with se-
quence similarity 24, member A [HGNC accession num-
ber 23470]). These SNPs, which were in LD with each
other but were not in LD with the associated SNPs in
LOC387715 (fig. 1), showed independent evidence for
association with AMD risk, although at much lower
statistical significance (MAFcases ∼55%; MAFcontrols ∼48%;
P range .0002–.0058). Case-control association results
for all 185 SNPs are shown in table 5.
GIST Analysis
Seven SNPs with P values .0019 in the case-control
analysis were statistically significant by the FDR crite-
rion ( ). These seven SNPs were(0.05# 7)/185p 0.0019
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Figure 1 LD pattern in 492.8-kb region from PLEKHA1 to CUZD1. The relative physical position of each SNP is given in the upper
diagram, and the pairwise D′ between all SNPs is given below each SNP combination. Red-shaded squares indicate . When′ ′D 1 0.80 D p
, no number is given inside the square, and the result is either significant (red) or nonsignificant (blue) on the basis of the Haploview default1.0
definition.44
analyzed with GIST to test whether they explained the
linkage signal in the region. Under the additive weighting
scheme suggested by the case-control analysis,34 only the
four SNPs in LOC387715 were significant in the GIST
analysis (table 4). This suggests that LOC387715 alone
is responsible for the 10q26 linkage evidence.
Conditional Haplotype Analysis
With the combined case-control data set, we used con-
ditional haplotype modeling to identify the statistically
most likely AMD-susceptibility variant from among all
the SNPs with strong evidence of association. We tested
each SNP in table 4, conditioning on the risk allele of
the most strongly associated SNP in CUZD1, FAM24A,
and LOC387715. Conditioning on the risk allele at
rs1891110 in CUZD1, rs10490924 was strongly asso-
ciated ( ), whereas none of the other5Pp 7.6# 10
SNPs were significant ( ). Conditioning on the riskP 1 .05
allele at rs2293435 in FAM24A, rs10490924 was
strongly associated ( ), whereas none of05Pp 7.1# 10
the other SNPs were significant ( ). Only condi-P 1 .05
tioning on the risk allele at rs10490924 fully explained
the association signal in the region, such that none of
the other SNPs showed any evidence for association
( ). Thus, this analysis also strongly implicates theP 1 .6
T allele at LOC387715 as a major AMD-susceptibility
allele, consistent with the study by Rivera et al.15
Interaction Analysis
The results of the AIC modeling strategy (table 6)
suggested that the joint action of the Y402H and the
rs10490924 variants was best described by independent
multiplicative effects, without statistically significant evi-
dence of dominance effects or epistatic interaction. Pre-
vious data presented by our group38 and by others39 sug-
gested that the joint action of Y402H and cigarette
smoking was also best described by independent mul-
tiplicative effects. In contrast, we found strong evidence
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Figure 2 Results of linkage and association analysis. Left Y-axis, Two-point and multipoint LOD scores. Right Y-axis, Log10-transformed
P values from logistic regression of case-control data set, with additive coding (as described in the text) and adjusted for age and sex. For exact
P values in the 112–132-Mb region that are !103, see table 4.
Table 4
SNPs in the 112–132-Mb Region with in the Case-Control Association AnalysisP  .0019
SNP (Risk Allele) Gene Type MAFcases MAFcontrols ORhet (95% CI) ORhom (95% CI) P GIST P
rs10490924 (T) LOC387715 Ala69Ser .410 .259 1.65 (1.12–2.43) 5.73 (3.07–10.71) 83.13#10 .05
A124205188G
(ss51855976) (G)
LOC387715 Intronic .412 .257 1.70 (1.14–2.53) 6.04 (3.22–11.33) 81.34#10 .05
rs3750848 (G) LOC387715 Intronic .412 .257 1.66 (1.12–2.47) 5.93 (3.16–11.14) 82.38#10 .05
rs3750846 (G) LOC387715 Intronic .409 .264 1.52 (1.02–2.24) 5.54 (2.96–10.38) 71.44#10 .05
rs11248321 (A) CUZD1 Intronic .558 .490 1.40 (.89–2.22) 2.37 (1.42–3.96) .0009 .41
rs1891110 (G) CUZD1/FAM24B 5′ UTR (CUZD1);
Leu2Pro (FAM24B)
.568 .489 1.55 (.90–2.68) 3.24 (1.73–6.08) .0002 .51
rs2293435 (G) FAM24A 5′ UTR .537 .466 1.51 (.94–2.41) 2.65 (1.53–4.61) .0005 .26
NOTE.—ORs were adjusted for age and sex and estimated separately for heterozygous (ORhet) and homozygous (ORhom) carriers of the minor allele. P values are
from additive coding of SNP covariate, as described in the text. Significant P values for GIST are in bold italics.
of statistical interaction between smoking and genotypes
at rs10490924. The ADD_SMOKE_INT model pro-
vided a significantly better fit to the data, by 5.2 AIC
units, compared with the model without this term (ta-
ble 6). A significant product term with positive regres-
sion coefficient for smoking and rs10490924 (additive
coding) indicated more than multiplicative joint effects
( ). A case-only analysis of rs10490924 andPp .007
pack-years of smoking (as a continuous variable) also
supported the presence of gene-environment interaction
( , adjusted for age and sex). The relative fre-Pp .05
quency of TT genotypes in affected individuals increased
almost linearly with increasing pack-years of smoking,
with a corresponding decrease in GG genotype frequen-
cies (fig. 3A). This pattern was strikingly similar to re-
sults for simulated data when the disease status was
generated with a logistic regression model that included
a gene-environment interaction term.40 Genotype fre-
quencies at rs10490924 were not related to pack-years
of smoking in our control sample (fig. 3B), confirming
that the result for cases was due to gene-environment
interaction rather than population correlation of the two
factors.
The results of our model-fitting strategy suggested that
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Table 5
Case-Control Association Results for 185 SNPs in
the 112–132-Mb Region
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 6
Results of Fitting Two-Factor Models by Logistic
Regression, Adjusted for Age and Sex
Factor 2 and Model AIC
AIC
Differencea
Y402H (rs1061170):
MEAN 936.8 262.4
ADD1 852.0 177.6
ADD2 719.2 44.8
ADDBOTH 675.3 .9b
DOM1 851.5 177.1
DOM2 719.1 44.7
DOMBOTH 674.4 0c
ADDINT 677.2 2.8
ADDDOM 677.5 3.1
DOMINT 678.5 4.1
Smoking (ever vs. never):
MEAN 936.8 288.0
ADD 852.0 203.2
SMOKE 708.5 59.7
ADD_SMOKE 654.0 5.2
DOM 851.5 202.7
ADD_SMOKE_INT 648.8 0c
DOM_SMOKE_INT 652.4 3.6
NOTE.—Factor 1 is rs10490924. Detailed
model definitions are given in the “Subjects and
Methods” section.
a AIC difference is the difference from the AIC
of the best-fitting model.
b Most parsimonious model.
c Best fit.
the most parsimonious model for estimating joint ORs
for all combinations of smoking history and the risk
variants in CFH and LOC387715 was one that included
main effect terms for smoking, genotypes GT and TT
at rs10490924, genotypes TC and CC at Y402H, and
two interaction (product) terms: one for smoking and
the GT genotype and one for smoking and the TT ge-
notype. The nonsmoker/GG/TT combination was used
as the referent group for all ORs (table 7). For non-
smokers, the combination of the TC genotype at Y402H
and the GT genotype at LOC387715 conferred a 1.8-
fold increase in AMD risk, and the combination of
the CC genotype at Y402H and the TT genotype at
LOC387715 conferred a 10-fold increase in risk. In
the absence of either susceptible genotype, the effect of
cigarette smoking was not significantly different from
1.0. The effect of Y402H was similar for smokers and
nonsmokers, with the most common genotype GG at
rs10490924, with an OR of ∼1.4 for the TC genotype
and ∼4.5 for the CC genotype. However, in the presence
of the susceptible genotype at rs10490924, the effect of
cigarette smoking was two- to three-times stronger than
under a simple multiplicative model. For example, the
OR for individuals with the TC genotype at Y402H and
the TT genotype at LOC387715 increased from 3.2 for
nonsmokers to 10.8 for smokers, and the OR for in-
dividuals with the CC genotype at Y402H and the TT
genotype at LOC387715 increased from 10.2 for non-
smokers to 34.5 for smokers (table 7). Averaged across
Y402H genotypes, the presence of the susceptibility al-
lele in LOC387715 did not confer a significantly in-
creased risk of AMD to nonsmokers (for the GT ge-
notype, OR 1.2, 95% CI 0.6–2.2, ; for the TTPp 0.59
genotype, OR 2.1, 95% CI 0.8–5.1, ). However,Pp .12
in smokers, the GT genotype increased the risk 2.7-fold
(95% CI 1.5–4.9; ), and the TT genotype in-Pp .001
creased the risk 8.2-fold (95% CI 3.5–19.2; ).P ! .0001
Table 8 shows the exposure frequencies for smoking and
the four susceptible genotypes at CFH and LOC387715
in controls, as well as the estimated population-attrib-
utable risk percentage (PAR%) for each factor, with ad-
justment for the other two factors.41 In our data set,
smoking accounted for ∼20% of AMD, rs10490924 for
∼36%, and Y402H for ∼43%, consistent with our pre-
vious report.7 The summary PAR% for all three factors
was 61.0%, which is less than the sum of the adjusted
PAR% estimates because exposures were not mutually
exclusive.
Family-Based Gene-Environment Interaction Analysis
The highly significant association of AMD with
rs10490924 that was observed in the initial case-control
analysis was not replicated in the family-based analysis
with the APL test. This could be because of the smaller
size of our family-based data set or because of between-
family heterogeneity. To test the latter possibility, we
applied OSA to our multiplex family data set, using the
average pack-years of smoking in affected individuals as
the OSA covariate (ordered from high to low). OSA
indicated that the majority of linkage evidence in the
10q26 region was contributed by only 40 families, with
an average of 44 pack-years of smoking (fig. 4). The
difference in nonparametric LOD scores between the 90
multiplex families with sufficient information to calcu-
late average smoking pack-years and the 40 families with
heavy smokers was significant ( ) on the basisPp .048
of 10,000 runs of the OSA permutation test.37 When the
APL analysis was repeated using only multiplex and sin-
gleton families that met the “heavy smoking” criterion
in affected individuals (family average of 44 pack-
years of smoking; 46 families total), the results con-
firmed the case-control association analysis; the APL P
value for rs10490924 and rs3750848 in LOC387715
was .02. Three SNPs in other genes also had P values
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Figure 3 A, Genotype frequencies at rs10490924 in unrelated
patients with AMD, by pack-years of cigarette smoking. The number
of individuals is shown above each bar. Of 314 reported smokers in
this group, 67 did not provide information on smoking duration and/
or the average number of packs smoked per day. B, Genotype fre-
quencies at rs10490924 in unrelated controls without AMD, by pack-
years of cigarette smoking. The number of individuals is shown above
each bar. Of 105 reported smokers in this group, 21 did not provide
information on smoking duration and/or average number of packs
smoked per day.
Table 7
Estimated Joint ORs and 95% CIs for Smoking History (Ever vs. Never), Genotype at rs10490924 in LOC387715, and Genotype at Y402H
in CFH
rs10490924
GENOTYPE
OR (95% CI) FOR
Nonsmoker and
Y402H Genotype
Smoker and
Y402H Genotype
TT TC CC TT TC CC
GG 1.0 (Ref) 1.42 (.87–2.33) 4.56 (2.55–8.18) .87 (.49–1.57) 1.24 (.57–2.72) 3.99 (1.75–9.12)
GT 1.24 (.65–2.37) 1.76 (.78–3.99) 5.66 (2.36–13.60) 2.48 (1.33–4.59) 3.52 (1.55–8.01) 11.30 (4.75–26.90)
TT 2.24 (.85–5.88) 3.18 (1.08–9.39) 10.21 (3.27–31.94) 7.56 (3.15–18.14) 10.75 (3.92–29.49) 34.51 (11.87–100.32)
NOTE.—Estimated from 511 patients with AMD (grades 3–5) and 208 controls (grades 1–2) with complete data on the three factors of
interest and adjusted for age and sex. Ref p referent.
of .02: rs760336 in PRSS11 (adjacent to LOC387715),
rs1052715 in DMBT1 (deleted in malignant brain tu-
mors 1 [MIM 601969]), and hcv2917031 in GPR26 (G
protein-coupled receptor 26 [MIM 604847]). Neither
SNP had a case-control association in the overallP ! .05
analysis.
Clinical Subgroup Analysis
It is of great clinical interest to determine whether the
LOC387715 association is present for both geographic
atrophy (grade 4) and neovascular AMD (grade 5). Our
data set had limited statistical power for the AMD sub-
type comparison because it included a much smaller
number of patients with geographic atrophy than of pa-
tients with choroidal neovascularization (table 1), and
because smoking-history information was not available
for all study participants. Therefore, we did not calculate
rs10490924 genotype frequencies across AMD grades
separately for smokers and nonsmokers.
Table 9 shows that the frequency of the T allele was
higher in patients with choroidal neovascularization
(47.6%) than in patients with geographic atrophy
(39.0%), but the clinical interpretation of this finding
awaits replication in an independent data set that in-
cludes large numbers of patients with each of these AMD
subtypes.
Discussion
Using iterative high-density SNP association mapping,
we identified a coding change in LOC387715, at SNP
rs10490924, to be the most likely major AMD-suscep-
tibility allele on chromosome 10q26, the second iden-
tified to date. We also, for the first time, presented sta-
tistical evidence of gene-environment interaction for this
variant, suggesting that a genetic susceptibility coupled
with a modifiable lifestyle factor, such as cigarette smok-
ing, confers a significantly higher risk of AMD than ei-
ther factor alone. Genotype frequencies at rs10490924
were strongly correlated with pack-years of smoking in
patients with AMD, consistent with heterogeneity anal-
ysis of the genetic linkage data. It is striking that we
have observed evidence for gene-environment interac-
tion in two different data sets, using two statistically
independent approaches. However, the presence of sta-
tistical interaction does not prove biological interaction,
and much work remains to be done to identify the mo-
lecular mechanism underlying the increased AMD risk.
Our data did not support the previously reported
association of AMD with the GRK5/RGS10 region14
at ∼121 Mb, because the four SNPs (hcv1809962,
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Table 8
Exposure Frequencies for Smoking and Susceptible
Genotypes at LOC387715 and CFH in 208
Controls (Grades 1–2) and PAR% for Each
Exposure, Adjusted for the Other Two Factors41
Exposure
Frequency
in Controls
(%)
Adjusted
PAR%
Cigarette smoking (ever) 49.8 20.0
rs10490924:
GT 34.6 36.3
TT 9.0
CFH Y402H:
TC 53.9 42.6
CC 16.0
NOTE.—Summary PAR% for all three factors is
61.0%, which is less than the sum of the adjusted
PARs because exposures are not mutually exclusive.
Figure 4 OSA of 90 multiplex AMD-affected families with information on pack-years of cigarette smoking. Dashed line, Multipoint
LOD* in 90 families. Solid line, Multipoint LOD* in 40 families with 44 pack-years, averaged across family members with AMD.
rs871196, rs1537576, and rs1467813) that we geno-
typed in this region did not demonstrate significant as-
sociation ( ). The GIST and conditional haplotypeP 1 .05
analyses suggested that only rs10490924, and the sur-
rounding LOC387715 SNPs in high LD with it, ex-
plained the linkage and association signals in this re-
gion. Neither analysis supported SNPs in the nearby
PLEKHA1 and PRSS11 genes as being responsible for
the linkage or association evidence. Consistent with
these results, the most-significant single-SNP associa-
tions, the highest ORs, and the highest nonparametric
two-point LOD score of 3.2 were contributed by SNPs
in LOC387715. Although we did not resequence the
nearby PLEKHA1 and PRSS11 genes, we genotyped the
vast majority of SNPs examined by the earlier studies
in our data set, including all known nonsynonymous
coding SNPs spanning the region between and including
these two genes. Several SNPs in CUZD1, which is not
in LD with the PLEKHA1/LOC387715 LD block, gave
substantial association signals with logistic regression
(smallest ), but allele frequency differences inPp .0002
cases and controls were much less pronounced for these
SNPs (MAFcases ∼55%; MAFcontrols ∼48%) compared with
the SNPs in LOC387715 ( ∼41%; MAFcontrolsMAFcases
∼26%). In addition, the GIST method and the condi-
tional haplotype analysis suggested that these SNPs did
not explain the linkage and association signals in this
region.
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Table 9
MAF and Genotype Frequency at rs10490924, by AMD Grade
AMD
GRADE MAF
FREQUENCY OF rs10490924 GENOTYPE
(NO. OF INDIVIDUALS WITH GENOTYPE)
GG GT TT
1 .275 .520 (140) .409 (110) .071 (19)
2 .307 .479 (57) .429 (51) .092 (11)
3 .318 .460 (115) .444 (111) .096 (24)
4 .390 .404 (55) .412 (56) .184 (25)
5 .476 .295 (177) .458 (275) .247 (148)
NOTE.—Estimated by combining family-based and case-control data
sets, including related individuals.
The limitations of any retrospective epidemiologic
study apply to our findings, including the potential for
recall bias of past exposures. The validity of the sum-
mary PAR% estimates depends on the extent to which
our case-control data set is representative of a popula-
tion-based sample of patients with AMD and controls.
Since our data set was used to identify the susceptibility
variant in LOC387715, it is possible that its effect size,
and thus its PAR%, was overestimated.42,43 Independent
large population-based studies, ideally collected in a pro-
spective fashion, are needed to confirm the statistical
interaction between smoking and rs10490924 in con-
tributing to AMD and its clinical subtypes and to refine
estimates of their individual and joint PAR%s. Because
of the high prevalence of smoking, its interaction with
genotypes at LOC387715 induces a strong marginal ef-
fect, which explains why our study and others14,15 de-
tected significant association signals even when smoking-
history information was not included in the analysis. The
frequencies of the T allele in smokers (40.4%) and non-
smokers (41.4%) with AMD were very similar in the
study by Rivera et al.,15 but were quite different in our
study (45.7% in smokers; 38.4% in nonsmokers). The
reason for this difference is not clear, but the two samples
are also quite different with respect to the reported pro-
portion of smokers (in Rivera et al., 25.2% of the 842
patients with information on smoking history; in our
study, 60.3% of 521). The controls in our data set have
a lower mean age at examination, and thus some of them
may develop AMD in the future. This may explain why
the estimated allele frequency of rs10490924 in our data
set (25.8%) is slightly higher than that reported by Ri-
vera et al. (19.6%). It suggests that the inclusion of youn-
ger controls in our study is more likely to have created
a bias toward the null, rather than an overestimated
effect of this SNP on the risk of AMD.
There is currently no biological explanation for the
mechanism by which LOC387715 may increase the risk
of AMD. It is not clear whether this statistical associ-
ation provides further support for the role of the innate
immunity system that was highlighted by the recent dis-
covery of CFH. LOC387715 is a two-exon gene that
encodes a protein of 107 aa, whose only homologue is
a chimpanzee gene with 97% protein identity. No sig-
nificant matches were found with any known protein
motifs. ESTs have been recovered from the placenta and
the testis, and this gene has recently been reported to be
weakly expressed in the retina.15
In summary, we have replicated and refined previous
reports implicating a coding change in LOC387715 as
the second major AMD-susceptibility allele. The effect
of rs10490924 appears to be completely independent of
the Y402H variant in CFH. The joint effect of these two
susceptibility genes is consistent with a multiplicative
model. Previous data reported by our group38 and by
others39 suggested that the joint effects of CFH and
smoking are also consistent with a multiplicative model.
In contrast, the effect of rs10490924 appears to be
strongly modified by cigarette smoking. Although the
marginal effect of this SNP was strong enough to be
detected without incorporation of smoking-history in-
formation, an effect modification of a genetic suscepti-
bility by a lifestyle factor such as smoking has important
implications for the clinical interpretation of this finding.
Our data suggest that the T allele at rs10490924 may
only moderately increase the AMD risk in nonsmokers
and likely exerts its strongest effect on heavy smokers.
This has the potential to reduce the impact of an AMD-
susceptibility allele on the aging population through
public health efforts such as smoking-prevention and
smoking-cessation programs. Our replication of the
10q26 linkage heterogeneity due to smoking and the
consistency of results from multiple statistically inde-
pendent approaches for assessing gene-environment in-
teraction reported here are unusual in genetic studies of
complex human diseases and provide substantial sup-
port for our findings. The obvious next task is to ex-
amine the function of LOC387715 in AMD-relevant
tissue at the molecular level, particularly in light of the
role it may play in smoking-associated pathways leading
to this devastating disorder.
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